Circulating Tumor Markers in Breast Cancer

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1965 • 2,318 citations

REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY

1985 • 1,760 citations

Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.

1988 • 935 citations

Carcinoembryonic Antigen

1986 • 445 citations

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.

1986 • 331 citations

Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

1988 • 310 citations

The Value of Mammography Screening in Women Under Age 50 Years

1988 • 257 citations

Antigenicity of Pooled Human Malignant and Normal Tissues by Cyto-Immunological Technique: Presence of an Insoluble, Heat-Labile Tumor Antigen

1957 • 212 citations

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.

1985 • 211 citations

Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress

1974 • 210 citations

Polyamines as markers of response and disease activity in cancer chemotherapy.

1977 • 202 citations

Measurement of Serum Ferritin by Radioimmunoassay: Results in Normal Individuals and Patients With Breast Cancer 2

1975 • 165 citations

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

1988 • 160 citations

MAM-6 antigen, a new serum marker for breast cancer monitoring.

1986 • 135 citations

Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancer

1984 • 120 citations

Circulating human mammary epithelial antigens in breast cancer.

1982 • 115 citations

Value of CA 15:3 in the follow-up of breast cancer patients

1987 • 109 citations

Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma

1978 • 89 citations

A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.

1978 • 86 citations

Evaluation of a Breast Cyst Fluid Protein Detectable in the Plasma of Breast Carcinoma Patients

1977 • 86 citations

Biochemical prediction of response of bone metastases to treatment

1988 • 85 citations

Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.

1985 • 85 citations

Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer

1975 • 83 citations

Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.

1986 • 79 citations

Identification of a family of high molecular weight tumor-associated glycoproteins.

1987 • 71 citations

Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients

1985 • 70 citations

Sequential Carcinoembryonic Antigen Levels in the Therapy of Metastatic Breast Cancer

1978 • 69 citations

Carcinoembryonic antigen in breast cancer

1978 • 69 citations

Clinical correlation between CEA and breast cancer

1978 • 68 citations

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer

1988 • 67 citations

RADIOIMMUNOASSAY OF SERUM CREATINE KINASE-BB AS A TUMOUR MARKER IN BREAST CANCER

1980 • 65 citations

Osteocalcin: a potential marker of metastatic bone disease and response to treatment

1988 • 62 citations

Urinary hydroxyproline excretion in patients with cancer

1969 • 61 citations

Mucin-like carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes.

1988 • 59 citations

Carcinoembryonic antigen in breast cancer. Clinical review

1986 • 57 citations

Hydroxyproline excretion in patients with breast cancer and response to treatment.

1975 • 49 citations

Human Tissue Polypeptide Antigen in Breast Cancer

1979 • 49 citations

Biological markers for breast carcinoma

1984 • 47 citations

Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer

1981 • 47 citations

Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.

1984 • 43 citations

A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer

1989 • 43 citations

Urine Hydroxyproline Excretion-a Marker of Bone Metastases in Prostatic Carcinoma

1977 • 43 citations

Serial Plasma Carcinoembryonic Antigen Measurements During Treatment of Metastatic Breast Cancer

1983 • 41 citations

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer

1987 • 40 citations

Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.

1986 • 37 citations

Carcinoembryonic antigen in patients with breast cancer.An adjunctive tool to monitor response and therapy

1978 • 36 citations

Screening for metastases in breast cancer: An assessment of biochemical and physical methods

1981 • 33 citations

Prognostic significance of CEA in breast cancer: a statistical study

1981 • 31 citations

Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer

1984 • 31 citations

A new biomarker in monitoring breast cancer: CA 549.

1988 • 31 citations

The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma

1978 • 30 citations

Use of ceruloplasmin levels to monitor response to therapy and predict recurrence of breast cancer

1983 • 30 citations

Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasis

1981 • 28 citations

Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy

1982 • 27 citations

Monitoring breast cancer with CA 549.

1988 • 25 citations

Detection of mammary micrometastases by pregnancy-associated α2-glycoprotein (PAG, α2-PAG or PAM) and carcinoembryonic antigen (CEA)

1979 • 24 citations

Evaluation of CA15/3 serum levels in breast cancer patients.

1986 • 24 citations

Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen

1982 • 23 citations

Elevated serum alpha fetoprotein levels in postmenopausal women with primary breast carcinoma.

1987 • 21 citations

The Postabsorptive Hydroxyproline in the Long-Term Evaluation of Patients With Breast Cancer

1983 • 21 citations

Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.

1988 • 21 citations

Application of mammary serum antigen assay in the management of breast cancer: A preliminary report

1988 • 20 citations

The Value of Serial Plasma Levels of Carcinoembryonic Antigen and Gross Cyst Disease Fluid Protein in Patients with Breast Carcinoma and Osseous Metastases

1980 • 20 citations

Serial tests of carcinoembryonic antigen in patients with breast cancer

1983 • 20 citations

Evaluation of MSA as a serum marker in breast cancer: A comparison with CEA

1988 • 19 citations

Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancer

1987 • 19 citations

Biologic markers in breast carcinoma: Clinical correlations with urinary polyamines

1980 • 17 citations

Comparison of mammary serum antigen assay with mammography in patients with breast cancer

1988 • 16 citations

Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.

1979 • 16 citations

Serum tumor markers in metastatic breast cancer and course of disease.

1983 • 16 citations

Three-centre study on urinary hydroxyproline excretion in cancer of the breast

1978 • 15 citations

Laboratory Testing for Cancer

1977 • 14 citations

Study of serum β-2 microglobulin levels in breast cancer patients

1979 • 14 citations

Carcinoembryonic antigen as a monitor of recurrent breast cancer

1982 • 13 citations

Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.

1980 • 12 citations

Serum levels of placental protein 10 (PP10) in women with breast cancer and genital carcinoma and in healthy male and female subjects

1983 • 10 citations

Slope analysis of plasma carcinoembryonic antigen levels in monitoring response to treatment in patients with metastatic carcinoma of the breast.

1980 • 10 citations

Determination of TPA levels in breast cancer and controls

1983 • 10 citations

Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.

1980 • 10 citations

Post-operative serum sialyltransferase levels and prognosis in breast cancer

1983 • 10 citations

Carcino-embryonic antigen assay as a guide to tumour bulk, response to therapy and prognosis in human breast cancer

1980 • 9 citations

Double antibody radioimmunoassay for monitoring metastatic breast cancer

1988 • 9 citations

Sequential galactosyltransferase and carcinoembryonic antigen levels in advanced breast carcinoma

1981 • 8 citations

Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control.

1985 • 7 citations

The Role of Carcinoembryonic Antigen in the Postmastectomy Follow-Up of Primary Breast Cancer and in the Prognostic Evaluation of Disseminated Breast Cancer

1984 • 6 citations

Diagnostic and prognostic value of TPA in breast cancer.

1985 • 4 citations